IP3R Modulation by Cancer Genes in Mesothelioma
NCT03558932 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2018-06-15
Summary
Obtaining pleural biopsies in cases of malignant mesothelioma to detect molecular mechnisms and signal transduction
Conditions
- Malignant Mesothelioma
Interventions
- DIAGNOSTIC_TEST
-
pleural biopsy
diagnostic sampling
Sponsors & Collaborators
-
KU Leuven
lead OTHER
Principal Investigators
-
Jonas Yserbyt · Catholic university Leuven
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-31
- Primary Completion
- 2023-12-31
- Completion
- 2024-06-30
More Related Trials
-
The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment
NCT03873103 ·Status: UNKNOWN
-
Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
NCT03830229 ·Status: RECRUITING
-
Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma
NCT04823741 ·Status: RECRUITING
-
Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients with Metastatic Malignant Melanoma Treated with Targeted Therapies or Immunotherapy ( MALT )
NCT03493230 ·Status: COMPLETED ·Phase: NA
-
Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients
NCT02300883 ·Status: COMPLETED
-
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
NCT01148407 ·Status: UNKNOWN
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
NCT02251314 ·Status: COMPLETED
-
Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma
NCT02269878 ·Status: COMPLETED
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
Treatment of Multifocal Lung Adenocarcinoma
NCT01946100 ·Status: TERMINATED ·Phase: NA
-
Intravital Microscopy in Human Solid Tumors
NCT03823144 ·Status: RECRUITING ·Phase: NA
-
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
NCT00897247 ·Status: COMPLETED
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073 ·Status: RECRUITING
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
NCT03596593 ·Status: UNKNOWN ·Phase: NA
-
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250 ·Status: COMPLETED
-
The Aim is to Identify Recurrent Genomic Mutations and/or Predisposing Polymorphisms in Patients With Sporadic Cases of Multiple Myeloma
NCT05331313 ·Status: UNKNOWN
-
Implementation of the Methylome in the Characterization of Solid Tumors
NCT07268066 ·Status: RECRUITING
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
NCT01057095 ·Status: COMPLETED